Fourth, consistency and stability of the association between serum insulin levels and NAFLD prevalence were validated from multiple perspectives through RCS analysis, sensitivity analyses, and subgroup analyses, enhancing the credibility of the findings. This evidence concerns the gene INS and metabolic dysfunction-associated steatotic liver disease.